Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-13-043451
Filing Date
2013-09-09
Accepted
2013-09-09 12:34:38
Documents
2
Period of Report
2013-09-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2344
2 POA DOCUMENT poa.txt EX-24.3_487240 3055
  Complete submission text file 0001209191-13-043451.txt   6811
Mailing Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 (514) 337-3333
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MIRATI THERAPEUTICS, INC. 9363 TOWNE CENTRE DRIVE, STE 200 SAN DIEGO CA 92121
Business Address
CHEN ISAN (Reporting) CIK: 0001586218 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35921 | Film No.: 131084925